169 related articles for article (PubMed ID: 8199021)
1. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro.
Robson SC; Shephard EG; Kirsch RE
Br J Haematol; 1994 Feb; 86(2):322-6. PubMed ID: 8199021
[TBL] [Abstract][Full Text] [Related]
2. FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line.
Hamaguchi M; Morishita Y; Takahashi I; Ogura M; Takamatsu J; Saito H
Blood; 1991 Jan; 77(1):94-100. PubMed ID: 1845845
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors.
Robson SC; Saunders R; Kirsch RE
J Clin Lab Immunol; 1990 Oct; 33(2):83-90. PubMed ID: 1967070
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
[TBL] [Abstract][Full Text] [Related]
5. Fibrin stimulates microfilament reorganization and IL-1beta production in human monocytic THP-1 cells.
Lee ME; Kweon SM; Ha KS; Nham SU
Mol Cells; 2001 Feb; 11(1):13-20. PubMed ID: 11266115
[TBL] [Abstract][Full Text] [Related]
6. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
7. Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts.
Hagood JS; Olman MA; Godoy JA; Rivera KE; Fuller GM
Blood; 1996 May; 87(9):3749-57. PubMed ID: 8611700
[TBL] [Abstract][Full Text] [Related]
8. Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes.
Vasse M; Mirshahi SS; Soria J; Mirshahi M; Borg JY; Monconduit M; Soria C
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):143-7. PubMed ID: 8457643
[TBL] [Abstract][Full Text] [Related]
9. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
10. Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell-dependent lymphocyte mitogenesis.
Robson SC; Saunders R; Purves LR; de Jager C; Corrigall A; Kirsch RE
Blood; 1993 Jun; 81(11):3006-14. PubMed ID: 8499635
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes.
Hamilton JA; Whitty GA; Last K; Royston AK; Hart PH; Burgess DR
Blood; 1992 Jul; 80(1):121-5. PubMed ID: 1611080
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver.
Mandl J; Csala M; Léránt I; Bánhegyi G; Biró J; Machovich R; Falus A
Scand J Immunol; 1995 Jul; 42(1):175-8. PubMed ID: 7631139
[TBL] [Abstract][Full Text] [Related]
15. Fibrin D-dimer impairs the accumulation and anticoagulant properties of heparan sulphate and stimulates secretion of plasminogen activator inhibitor-1 by rabbit coronary endothelial cells.
Yevdokimova NY; Veselovska LD; Gogolinska GK; Buchanevich OM; Kosyakova GV; Gritsenko PG; Lugovskoj EV; Komisarenko SV
Acta Biochim Pol; 2003; 50(1):279-89. PubMed ID: 12673370
[TBL] [Abstract][Full Text] [Related]
16. Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy.
Paniccia R; Prisco D; Bandinelli B; Fedi S; Giusti B; Pepe G; Abbate R
Thromb Res; 2002 Feb; 105(3):257-62. PubMed ID: 11927132
[TBL] [Abstract][Full Text] [Related]
17. Monocytes enhance the bidirectional release of type I plasminogen activator inhibitor by endothelial cells.
Hakkert BC; Rentenaar JM; van Mourik JA
Blood; 1990 Dec; 76(11):2272-8. PubMed ID: 2257301
[TBL] [Abstract][Full Text] [Related]
18. D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.
Park YJ; Acosta D; Vassell R; Tang J; Khurana S; Weiss CD; Golding H; Zaitseva M
PLoS Pathog; 2022 Apr; 18(4):e1010468. PubMed ID: 35385545
[TBL] [Abstract][Full Text] [Related]
19. [The antifibrinolytic action of the D-dimer fragment].
Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
[TBL] [Abstract][Full Text] [Related]
20. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
Gyetko MR; Shollenberger SB; Sitrin RG
J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
